MS
RETA

Maven Securities’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Maven Securities’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Hold
2023
Q3 		– Hold
2020
Q1 		– Sell
2019
Q4 		$10.3M Buy